Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikki M Carroll

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced CancerMatthew P Banegas, Michael J Hassett, Erin M Keast, et al.
Health Services Research|July 26, 2018
Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at DiagnosisDebra P Ritzwoller, Paul A Fishman, Matthew P Banegas, et al.
Clinical Lung Cancer|September 18, 2016
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung CancerAlex R Menter, Nikki M Carroll, Lori C Sakoda, et al.
Journal of General Internal Medicine|January 25, 2020
Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-ConcordanceNikki M Carroll, Andrea N Burnett-Hartman, Caroline A Joyce, et al.
Cancer Treatment and Research Communications|June 23, 2023
Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancerNikki M Carroll, Jennifer Eisenstein, Andrea N Burnett-Hartman, et al.
Public Health Genomics|April 15, 2020
Return of Research-Related Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse GroupsAndrea N Burnett-Hartman, Erica Blum-Barnett, Nikki M Carroll, et al.
Journal of Genetic Counseling|November 22, 2019
Demographic differences in the utilization of clinical and direct-to-consumer genetic testingNikki M Carroll, Erica Blum-Barnett, Sarah D Madrid, et al.
Cancer Epidemiology|February 19, 2025
Patterns of recurrence among adults diagnosed with screen-detected lung cancerNikki M Carroll, Jennifer Eisenstein, Kris F Wain, et al.
American Journal of Epidemiology|February 11, 2017
Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older WomenMarsha A Raebel, Chan Zeng, T Craig Cheetham, et al.
JAMA Network Open|October 12, 2021
Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care SystemsDebra P Ritzwoller, Rafael Meza, Nikki M Carroll, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced CancerMatthew P Banegas, Michael J Hassett, Erin M Keast, et al.
Health Services Research|July 26, 2018
Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at DiagnosisDebra P Ritzwoller, Paul A Fishman, Matthew P Banegas, et al.
Clinical Lung Cancer|September 18, 2016
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung CancerAlex R Menter, Nikki M Carroll, Lori C Sakoda, et al.
Journal of General Internal Medicine|January 25, 2020
Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-ConcordanceNikki M Carroll, Andrea N Burnett-Hartman, Caroline A Joyce, et al.
Cancer Treatment and Research Communications|June 23, 2023
Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancerNikki M Carroll, Jennifer Eisenstein, Andrea N Burnett-Hartman, et al.
Public Health Genomics|April 15, 2020
Return of Research-Related Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse GroupsAndrea N Burnett-Hartman, Erica Blum-Barnett, Nikki M Carroll, et al.
Journal of Genetic Counseling|November 22, 2019
Demographic differences in the utilization of clinical and direct-to-consumer genetic testingNikki M Carroll, Erica Blum-Barnett, Sarah D Madrid, et al.
Cancer Epidemiology|February 19, 2025
Patterns of recurrence among adults diagnosed with screen-detected lung cancerNikki M Carroll, Jennifer Eisenstein, Kris F Wain, et al.
American Journal of Epidemiology|February 11, 2017
Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older WomenMarsha A Raebel, Chan Zeng, T Craig Cheetham, et al.
JAMA Network Open|October 12, 2021
Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care SystemsDebra P Ritzwoller, Rafael Meza, Nikki M Carroll, et al.
Pageof 6